Insights & Resources | Pfizer CentreOne

Manufacturing Excellence is a Team Effort

Pfizer’s manufacturing excellence story can be likened to the sport of crew rowing, learn how the teamwork in rowing mirrors teamworking in pharmaceutical manufacturing.

Pfizer expands its major manufacturing network in Kalamazoo, Michigan

We are excited to announce our latest investment into our Kalamazoo facility

Five Best Practices to Ensure Quality Active Pharmaceutical Ingredients

In this blog we’ll explore the five key measures pharma companies must take to ensure the highest quality supply of their APIs.

The essential steps in evaluating a pre-filled syringe system

Learn about the essential steps developers must take when evaluating a pre-filled syringe system.

Checklist: The commodities you’ll need when migrating a drug product presentation from vial to pre-filled syringe

When migrating a drug product from vial to PFS, the closure must be screened for suitable parts. Take a look at our blog and checklist detailing what commodities you’ll need and when.

Liposomes – Challenges and Opportunities

Liposome technologies have become an important part of the drug delivery armory, discover more about them.

Overcoming supply chain and logistics challenges with Pfizer CentreOne

Managing your pharmaceutical supply chain is a lot like following a good cake recipe. Both require thorough preparation, a comprehensive plan of action, and the best ingredients that come together to make something special - your drug product.

Putting contract dose manufacturing trends under the spotlight

Contract dose manufacturers, including small-molecule and biologic outsourcing partners have had to respond rapidly in order to continue to meet customers’ rapidly shifting needs.

Uniting target product profile, regulatory partnering strategies are essential for sustainable product success

Drug sponsors know very well how essential it is to establish the TPP (Target Product Profile) of their prospective drug product as early as possible.

Making a case for a fixed dose combination drug strategy

Over the past two decades, pharma’s acute focus on the patient has driven great innovation and investment in ways to deliver active pharmaceutical ingredients (APIs) in finished drug products, we discuss how FDCs have been gaining favor.

Into a Post-COVID World: Overcoming Pharmaceutical Supply Chain Challenges and Unlocking CDMO Opportunities

In an industry that is ever-evolving, trends and opportunities unfold at every turn. Our Global Business Development Lead Tom Wilson recently spoke with CPhI Online to share his insights on recent supply chain challenges and discuss the opportunities in the CDMO space.

How has technology helped shape the innovation of drug dosage forms and support patient-centric goals?

What are the key drug dosage form trends happening in this space, and how can we expect them to change the future of patient-centric treatments? Our Director of Operations Dierdre Whelan discusses them in this piece.